Edit |   |
---|---|
Antigenic Specificity | CD279, Human (Tislelizumab biosimilar) |
Clone | Tislelizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD279 Recombinant Antibody (Tislelizumab). Tislelizumab (BGB-A317) is a humanized monoclonal antibody directed against PD-1. It prevents PD-1 from binding to the ligands PD-L1 and PD-L2 (hence it is a checkpoint inhibitor). It is being investigated as a treatment for advanced solid tumors. |
Immunogen | n/a |
Other Names | Anti-CD279 Recombinant Antibody, Research Grade Tislelizumab, Anti-Human CD279 Recombinant Antibody(Tislelizumab), BGB-A317, Antibody Drug Analogues, Monoclonal Antibody, YR1471, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1858168-59-8 |
Catalog # | YR1471 |
Price | please inquire |
Order / More Info | CD279, Human (Tislelizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |